Chris Calabrese | Investor Relations |
Hamid Erfanian | Chief Executive Officer |
David Bench | Chief Financial Officer |
J. P. Sullivan | Potomac Capital |
Greetings and welcome to the Enzo Biochem Third Quarter 2022 Financial Results and Business Update. At this all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I'd now like to turn the conference over to your host, Chris Calabrese, LifeSci Advisors, Investor Relations for Enzo Biochem.